<?xml version="1.0" encoding="UTF-8"?>
<ref id="B52-biomolecules-09-00138" class="ref">
 <label class="label">52.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Horev</surname>
    <given-names class="given-names">B.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Klein</surname>
    <given-names class="given-names">M.I.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Hwang</surname>
    <given-names class="given-names">G.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Li</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Kim</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Koo</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Benoit</surname>
    <given-names class="given-names">D.S.W.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">pH-activated Nanoparticles for Controlled Topical Delivery of Farnesol to Disrupt Oral Biofilm Virulence</article-title>
  <source class="source">ACS Nano</source>
  <year class="year">2015</year>
  <volume class="volume">9</volume>
  <fpage class="fpage">2390</fpage>
  <lpage class="lpage">2404</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1021/nn507170s</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">25661192</pub-id>
 </element-citation>
</ref>
